HAI or IV of Adebrelimab, Combined With Bevacizumab and HAI of FOLFOX for Advanced Unresectable Hepatocellular Carcinoma
Clinical trial NCT06737913 · RECRUITING
Trial details
- NCT number
- NCT06737913
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-03
- Primary completion
- 2028-06-30
- Enrollment
- 76
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.